What Are The Clinical Guidelines And Parameter Settings For Utilizing Intense Pulsed Light (Ipl) Equipment In The Treatment Of Vascular Lesions Like Small Venous Malformations And Hemangiomas? Key Protocols And Safety Tips

IPL can be used for selected superficial vascular lesions, but treatment settings must be individualized by lesion size, vessel depth and caliber, skin phototype, and the specific device. For small venous malformations under 100 cm², a commonly described protocol uses a 590 nm filter, long-pulse mode, triple pulses, and approximately 80 J/cm², often over two to three sessions. For centrofacial hemangiomas, reported settings are lower: a 590 nm filter, 36–45 J/cm², triple pulses, 2.5–6 ms pulse durations, and 20–30 ms delays.

IPL treatment is governed by controlled vascular heating, not by a single universal setting. The clinician should select the wavelength, fluence, pulse duration, pulse structure, and cooling method together, then adjust treatment according to the observed vascular endpoint and the patient’s skin-pigment risk.

Establish Whether IPL Is Appropriate

Confirm the Lesion Diagnosis

“Vascular lesion” is not a single treatment category. Small venous malformations, infantile hemangiomas, residual hemangiomas, telangiectasias, rosacea, and spider angiomas differ in vessel size, depth, blood flow, and natural history.

A vascular specialist or appropriately trained dermatologist should confirm the diagnosis before treatment. Some lesions require vascular laser treatment, sclerotherapy, surgery, or observation rather than IPL.

Consider Lesion Size and Depth

IPL is useful partly because its relatively large spot size can treat broad areas efficiently and can deliver energy into the dermis. This is most relevant for superficial or moderately deep lesions that can be reached by the selected wavelength.

Small venous malformations under approximately 100 cm² are the clearest protocol category in the supplied guidance. Larger, deeper, nodular, or high-flow lesions should not automatically be treated by extending the same fluence or pulse pattern.

Assess Skin Phototype

Epidermal melanin competes with hemoglobin for IPL energy. Shorter cutoff filters therefore carry greater risk of epidermal heating, particularly in darker or recently tanned skin.

Phototypes I and II may tolerate shorter filters more readily. Phototypes III and IV generally require longer cutoff filters, such as 570 or 590 nm, to reduce superficial melanin absorption.

Core IPL Parameters

Cutoff Filter

The cutoff filter removes shorter wavelengths and changes the depth and chromophore selectivity of the delivered spectrum.

Shorter filters, such as 515 or 550 nm, may be useful for small, superficial vessels in appropriately selected lighter skin. Longer filters, such as 570 or 590 nm, generally provide a safer approach when vessels are deeper or epidermal melanin absorption is a concern.

A 515 nm filter should be used cautiously on lower-extremity vessels because superficial melanin absorption can limit penetration and increase nonspecific thermal injury.

Fluence

Fluence is the energy delivered per unit area, expressed in J/cm². It must be high enough to produce vascular injury while remaining below the threshold for epidermal damage.

For small venous malformations under 100 cm², the supplied protocol describes approximately 80 J/cm² with a 590 nm filter in long-pulse, triple-pulse mode. This is a protocol reference, not a universal starting value; IPL platforms differ substantially in pulse delivery and calibration.

For centrofacial hemangiomas, the described fluence range is 36–45 J/cm² with a 590 nm filter and triple pulses. Facial skin generally warrants conservative escalation because swelling, blistering, and pigmentary complications are clinically conspicuous.

Pulse Duration

Pulse duration should correspond to the thermal behavior of the target vessel. Shorter pulses concentrate heat more rapidly, while longer pulses distribute heat over a longer interval and may be useful for larger or deeper vessels.

The hemangioma protocol specifies 2.5–6 ms pulse durations. More broadly, professional IPL systems may allow pulse durations from approximately 0.5 to 88.5 ms, but the available range should not be confused with a recommendation for any particular lesion.

Pulse Pattern and Delay

Triple-pulse delivery can permit epidermal cooling between pulses while building sufficient cumulative energy in the vessel. This is especially useful when a single pulse would require an unnecessarily high peak energy.

For centrofacial hemangiomas and larger vessels, the described inter-pulse delay is 20–30 ms. Smaller superficial vessels may respond to a single pulse or a faster double-pulse sequence, whereas larger vessels generally require more separated pulses.

Reference Protocols

Small Venous Malformations

For a lesion under approximately 100 cm², the supplied protocol is:

Filter: 590 nm
Mode: Long-pulse
Pulse pattern: Triple pulse
Fluence: Approximately 80 J/cm²
Typical course: Two to three sessions
Reported response: Approximately 70%–100% clearance in the referenced protocol

The reported clearance range should be interpreted cautiously. Response depends on lesion depth, blood flow, vessel caliber, skin type, anatomical site, and the definition of “clearance.”

Centrofacial Hemangiomas

For centrofacial hemangiomas, the supplied protocol is:

Filter: 590 nm
Fluence: 36–45 J/cm²
Pulse pattern: Triple pulse
Pulse duration: 2.5–6 ms
Pulse delay: 20–30 ms

These settings should be applied only after confirming that the lesion is suitable for IPL. “Hemangioma” may describe clinically different entities, and not every hemangioma should be managed with the same optical protocol.

Other Superficial Vascular Lesions

The supplementary guidance describes IPL as useful for conditions such as telangiectasias, rosacea-associated vessels, and cherry angiomas. However, the appropriate settings still depend on the vessel’s diameter, depth, and the patient’s pigment level.

Spider angiomas with a prominent central feeder vessel may be better addressed with a vascular laser or a device specifically suited to the feeder vessel. IPL should not be assumed to replace those modalities.

Judge the Clinical Endpoint

Expected Vascular Response

The desired endpoint is usually immediate vessel constriction or a clear color change, such as bright red becoming blue or purple. This reflects vascular heating and changes in hemoglobin absorption.

The endpoint should not be judged by redness alone. Excessive whitening, gray discoloration, epidermal whitening, blistering, or marked pain suggests excessive thermal injury and requires reassessment.

Use a Targeted Second Pass Carefully

If the vessel changes to blue or purple, a targeted second pass with a slightly longer pulse duration may take advantage of the altered absorption characteristics described in the supplementary guidance.

If the vessel continues to blanch under compression without coagulating, a focal second pass using increased fluence or a shorter pulse duration may be considered. Such adjustments should be conservative and limited to the remaining target vessels rather than automatically repeated across the entire treatment area.

Document the Response

Standardized photographs, lesion measurements, settings, cooling method, immediate endpoint, and delayed adverse effects improve treatment decisions across sessions.

A lack of response should prompt reassessment of diagnosis, depth, wavelength selection, and fluence rather than unrestricted escalation.

Cooling and Treatment Safety

Pre-Cooling

Chilled gel and device contact cooling should be used to reduce epidermal temperature and patient discomfort. Aggressive contact cooling is particularly important when treating broad areas or using higher fluences.

Cooling does not eliminate the risk of burns or pigmentary change. It supports epidermal protection but does not compensate for an unsuitable wavelength or excessive energy.

Post-Treatment Cooling

Ice packs or another appropriate cooling method should be applied after treatment. Patients should be warned that transient erythema and swelling can occur, especially on the face.

Blistering, prolonged pain, increasing tenderness, or significant crusting requires clinical review because these findings may indicate excessive thermal injury or another complication.

Eye and General Precautions

Appropriate wavelength-specific eye protection is essential for the patient and everyone in the treatment area. The device manufacturer’s safety requirements, treatment-room controls, and local clinical regulations must be followed.

Treatment should be deferred or modified when there is recent tanning, active skin inflammation or infection, impaired wound healing, or another condition that increases the risk of epidermal injury. Medication and photosensitivity risks also require review before treatment.

Understanding the Trade-Offs

More Energy Is Not Automatically Better

Higher fluence may improve vessel coagulation, but it also increases the risk of blistering, prolonged erythema, scarring, and post-inflammatory pigment alteration.

The practical objective is the lowest effective energy that produces a convincing vascular endpoint with acceptable epidermal response.

Shorter Wavelengths Improve Absorption but Raise Risk

Shorter cutoff filters can be effective for superficial vessels because hemoglobin absorbs strongly in that spectral region. They also increase melanin absorption, making them less forgiving in darker or tanned skin.

Longer filters reduce superficial melanin competition and penetrate more deeply, but may be less efficient for very small superficial vessels. Filter selection is therefore a balance between vessel targeting and epidermal protection.

IPL Is Not Risk-Free

The statement that vascular IPL is generally painless or risk-free is too broad. IPL can cause pain, erythema, edema, blistering, burns, pigmentary changes, scarring, and incomplete or uneven clearance.

The risk is reduced through appropriate patient selection, test spots, conservative parameter adjustment, cooling, eye protection, and competent follow-up, but it cannot be removed entirely.

Making the Right Choice for Your Goal

The safest protocol is one that combines the reference settings with lesion-specific assessment and a documented test response.

If your primary focus is treating a small venous malformation: Consider the 590 nm, long-pulse, triple-pulse protocol near 80 J/cm² as a reference for lesions under 100 cm², then individualize it according to depth, skin phototype, and clinical endpoint.
If your primary focus is treating a centrofacial hemangioma: Use the more conservative reference range of 36–45 J/cm² with triple pulses, 2.5–6 ms pulse durations, and 20–30 ms delays, with particularly careful facial cooling and monitoring.
If your primary focus is treating darker or tanned skin: Favor longer cutoff filters such as 570 or 590 nm and use conservative test areas because shorter wavelengths increase epidermal melanin absorption.
If your primary focus is treating a small superficial vessel: A shorter cutoff filter or single/faster double-pulse pattern may be appropriate only when skin pigmentation and anatomical site permit it.
If your primary focus is maximizing safety: Perform a diagnostic assessment and test spot, use chilled gel and contact cooling, document the vascular endpoint, and escalate only when the epidermis remains clinically unaffected.

Successful IPL treatment depends less on memorizing one setting than on matching wavelength, fluence, pulse timing, cooling, and patient characteristics to the actual vascular target.

Summary Table:

Parameter	Small Venous Malformations	Centrofacial Hemangiomas
Filter	590 nm	590 nm
Fluence	~80 J/cm²	36–45 J/cm²
Pulse Pattern	Triple pulse	Triple pulse
Pulse Duration	Long-pulse mode	2.5–6 ms
Pulse Delay	Not specified	20–30 ms
Sessions	2–3	Not specified

Ready to enhance your clinic's vascular treatment capabilities? BELIS offers professional IPL systems designed for safe and effective procedures. Contact our experts today to find the perfect device for your practice and receive personalized training and support. Contact us now.